(NASDAQ: SNGX) Soligenix's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 10.76%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.53%.
Soligenix's earnings in 2025 is -$9,588,012.On average, 1 Wall Street analyst forecast SNGX's earnings for 2025 to be -$10,086,829, with the lowest SNGX earnings forecast at -$10,086,829, and the highest SNGX earnings forecast at -$10,086,829. On average, 1 Wall Street analyst forecast SNGX's earnings for 2026 to be -$6,593,979, with the lowest SNGX earnings forecast at -$6,593,979, and the highest SNGX earnings forecast at -$6,593,979.
In 2027, SNGX is forecast to generate -$5,712,606 in earnings, with the lowest earnings forecast at -$5,712,606 and the highest earnings forecast at -$5,712,606.